| Nov 12 |
Mustang Bio Receives Positive Listing Determination from Nasdaq
|
| Nov 8 |
Mustang Bio’s MB-108 receives FDA orphan drug status for glioma treatment
|
| Nov 7 |
Mustang Bio granted orphan drug designation by FDA for its malignant glioma treatment
|
| Nov 7 |
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma
|
| Oct 23 |
Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
|
| Sep 13 |
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
|
| Jul 19 |
Mustang Bio files to sell 6.5M shares by holders
|
| Jun 28 |
Diamond Equity Research Releases Update Note on Enveric Biosciences Inc. (NASDAQ: ENVB)
|
| Jun 21 |
Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
|
| Jun 20 |
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
|
